Since doxorubicin promotes PKR-mediated cell death in mouse embryonic fibroblasts [26] and regulates PKR–eIF2α signaling in breast cancer cells [3], we tested the effects of PKR on doxorubicin-treated HCC1143 cells. Here, EIF2A is linked to breast carcinoma.